Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety

Neuropsychopharmacology

Volumn 36, Issue 13, 2011, Pages 2689-2697

  Browning, Michael ^a   Grol, Maud ^a   Ly, Verena ^a   Goodwin, Guy M ^a   Holmes, Emily A ^a   Harmer, Catherine J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

anxiety; cognitive bias; depression; emotional processing; memory; SSRI

Indexed keywords

CITALOPRAM;

ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; DEPRESSION; DRUG EFFICACY; EMOTIONAL INTELLIGENCE; EMOTIONAL STABILITY; EXPERIMENTAL MEDICINE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY CONSOLIDATION; MENTAL HEALTH; MOOD CHANGE; NEGATIVE SYNDROME; NORMAL HUMAN; PRIORITY JOURNAL; STRESS MANAGEMENT; TASK PERFORMANCE;

ANXIETY DISORDERS; CITALOPRAM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 80855147531     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.159     Document Type: Article

References (46)

1. Amir N, Beard C, Burns M, Bomyea J (2009). Attention modification program in individuals with generalized anxiety disorder. J Abnorm Psychol 118: 28-33.
2. Anderson N (1968). Likableness ratings of 555 personality trait words. J Pers Soc Psychol 9: 272-279.
3. Baert S, De Raedt R, Schacht R, Koster EH (2010). Attentional bias training in depression: therapeutic effects depend on depression severity. J Behav Ther Exp Psychiatry 41: 265-274.
4. Barlow DH, Gorman JM, Shear MK, Woods SW (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 283: 2529-2536. (Pubitemid 30324195)
5. Beck AT, Emery G, Greenberg RL (1985). Anxiety Disorders and Phobias: A Cognitive Perspective. Basic Books: New York.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 53-63.
7. Behar E, McHugh RK, Peckham A, Otto MW (2010). D-cycloserine for the augmentation of an attentional training intervention for trait anxiety. J Anxiety Disord 24: 440-445.
8. Blackwell SE, Holmes EA (2010). Modifying interpretation and imagination in clinical depression: a single case series using cognitive bias modification. Appl Cogn Psychol 24: 338-350.
9. Browning M, Holmes EA, Harmer CJ (2010a). The modification of attentional bias to emotional information: a review of the techniques, mechanisms, and relevance to emotional disorders. Cogn Affect Behav Neurosci 10: 8-20.
10. Browning M, Holmes EA, Murphy SE, Goodwin GM, Harmer CJ (2010b). Lateral prefrontal cortex mediates the cognitive modification of attentional bias. Biol Psychiatry 67: 919-925.
11. Clark DM (1983). On the induction of depressed mood in the laboratory: evaluation and comparison of the velten and musical procedures. Behav Res Ther 5: 27.
12. Cuijpers P, Dekker J, Hollon SD, Andersson G (2009a). Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. J Clin Psychiatry 70: 1219-1229.
13. Cuijpers P, van Straten A, Warmerdam L, Andersson G (2009b). Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety 26: 279-288.
14. Foa EB, Franklin ME, Moser J (2002). Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? Biol Psychiatry 52: 987-997. (Pubitemid 35356356)
15. Furukawa TA, Watanabe N, Churchill R (2007). Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews Article number: CD004364.
16. Hakamata Y, Lissek S, Bar-Haim Y, Britton JC, Fox NA, Leibenluft E et al (2010). Attention bias modification treatment: a meta-analysis toward the establishment of novel treatment for anxiety. Biol Psychiatry 68: 982-990.
17. Harmer CJ (2008). Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 55: 1023-1028.
18. Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM (2003). Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsycho-pharmacology 28: 148-152.
19. Harmer CJ, Cowen PJ, Goodwin GM (2011). Efficacy markers in depression. J Psychopharmacol, print copy in press (originally published online 8 June 2010, at http://jop.sagepub.com/content/early/2010/06/04/0269881110367722).
20. Harmer CJ, O'Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A et al (2009). Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry 166: 1178-1184.
21. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004). Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepi-nephrine reuptake inhibition. Am J Psychiatry 161: 1256-1263. (Pubitemid 38859176)
22. Hayes S, Hirsch CR, Mathews A (2010). Facilitating a benign attentional bias reduces negative thought intrusions. J Abnorm Psychol 119: 235-240.
23. Holmes EA, Lang TJ, Shah DM (2009). Developing interpretation bias modification as a "cognitive vaccine" for depressed mood: imagining positive events makes you feel better than thinking about them verbally. J Abnorm Psychol 118: 76-88.
24. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ et al (2000). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342: 1462-1470. (Pubitemid 30318269)
25. Klaassen T, Riedel WJ, van Someren A, Deutz NE, Honig A, van Praag HM (1999). Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry 46: 489-497. (Pubitemid 29369075)
26. Lundqvist D, Flykt A, Ohman A (1998). KDEF. Karolinska Hospital: Stockholm.
27. MacLeod CM, Koster EH, Fox E (2009). Whither cognitive bias modification research? Commentary on the special section articles. J Abnorm Psychol 118: 89-99.
28. MacLeod CM, Mathews A, Tata P (1986). Attentional bias in emotional disorders. J Abnorm Psychol 95: 15-20. (Pubitemid 17038587)
29. MacLeod CM, Rutherford E, Campbell L, Ebsworthy G, Holker L (2002). Selective attention and emotional vulnerability: assessing the causal basis of their association through the experimental manipulation of attentional bias. J Abnorm Psychol 111: 107-123. (Pubitemid 34150828)
30. Mathews A, MacLeod C (2005). Cognitive vulnerability to emotional disorders. Ann Rev Clin Psychol 1: 167-195. (Pubitemid 43843950)
31. Mathews A, Mogg K, Kentish J, Eysenck M (1995). Effect of psychological treatment on cognitive bias in generalized anxiety disorder. Behav Res Ther 33: 293-303.
32. Matsumoto D, Ekman P (1988). Japanese and Caucasian Facial Expressions of Emotion and Neutral Faces (JACFEE and JACNeuF). Human Interaction Laboratory, University of California: San Francisco.
33. Murphy SE, Yiend J, Lester KJ, Cowen PJ, Harmer CJ (2009). Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. Int J Neuropsychopharmacol 12: 169-179.
34. NICE (2007). Management of Anxiety (Panic Disorder, with or without Agoraphobia, and Generalised Anxiety Disorder) in Adults in Primary, Secondary and Community Care (Amended). NICE: London.
35. NICE (2009). Treatment and Management of Depression in Adults, Including Adults with a Chronic Physical Health Problem. NICE: London.
36. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C (2004). Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 61: 714-719. (Pubitemid 38890806)
37. Schlam TR (2008). The effect of attention training on emotional vulnerability and food consumption following a stressor. Ph.D. thesis, The State University of New-Jersey, Rutgers.
38. Schmukle SC (2005). Unreliability of the dot probe task. Eur J Pers 19: 595-605. (Pubitemid 43082619)
39. Spielberger CD, Gorsuch RL, Lushene RD (1983). Manual for the State-Trait Anxiety Inventory (STAI). Consulting Psychologists Press: Palo Alto, CA.
40. Spitzer RL, Williams JB, Gibbon M (2002). Structured Clinical Interview for the DSM-IV. New York State Psychiatric Institute: New York.
41. Tottenham N, Tanaka JW, Leon AC, McCarry T, Nurse M, Hare TA et al (2009). The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Res 168: 242-249.
42. Tranter R, Bell D, Gutting P, Harmer CJ, Healy D, Anderson IM (2009). The effect of serotonergic and noradrenergic antidepres-sants on face emotion processing in depressed patients. J Affect Disord 118: 87-93.
43. Velten Jr E (1968). A laboratory task for induction of mood states. Behav Res Ther 6: 473-482.
44. Watson D, Clark LA, Tellegen A (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54: 1063-1070.
45. Wells TT, Beevers CG (2009). Biased attention and dysphoria: manipulating selective attention reduces subsequent depressive symptoms. Cogn Emot 24: 719-728.
46. Wilson E, MacLeod CM (2003). Contrasting two accounts of anxiety-linked attentional bias: selective attention to varying levels of stimulus threat intensity. J Abnorm Psychol 112: 212-218. (Pubitemid 36583175)